Penumbra Inc

Penumbra Inc

PEN

Get informed when a big investor buys or sells

+ Follow
Market Cap$12.63B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Penumbra IncPenumbra Inc78.5-10%8.50.1
$327.50

Target Price by Analysts

2% upsidePenumbra Target Price DetailsTarget Price
$78.13

Current Fair Value

75.7% downside

Overvalued by 75.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.63 Billion
Enterprise Value$12.64 Billion
Dividend Yield$- (-)
Earnings per Share$4.57
Beta0.7
Outstanding Shares39,314,912

Return

Return on Equity10.49%ROE
Return on Assets8.13%
Return on Invested Capital11.50%

Valuation & Multiples

P/E Ratio78.53P/E Ratio
PEG-339.91PEG
Price to Sales8.45Price to Sales
Price to Book Ratio8.45Price to Book Ratio
Enterprise Value to Revenue8.4
Enterprise Value to EBIT63.16
Enterprise Value to Net Income78
Total Debt to Enterprise0.02
Debt to Equity0.14Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 30, 2026
EPS Estimate
$1.16
Average shareholder expectation
Revenue Estimate
$389.64 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 3, 2026
EPS Estimate
$1.16
Average shareholder expectation
Revenue Estimate
$389.64 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.6631 103.14%
Total Calls27,900 85.45%
Total Puts18,500 94.31%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.48% 85.48%
Total Invested$171.40M 98.46%
Investors Holding116 381.00%

ESG Score

No data

About Penumbra Inc

CEO: Adam Elsesser

Relevant Senate Committees

Finance

This committee controls taxation, trade, and entitlement spending, crucially influencing corporate valuations through tax policy and directly impacting medical device companies through Medicare pricing and reimbursement structures.

Appropriations

This committee allocates discretionary federal spending. Its subcommittees determine precise funding for various programs, including healthcare initiatives and research that directly impact government purchases of medical devices and related R&D.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary body for medical device approvals, and the NIH, which funds medical research. This oversight profoundly impacts Penumbra's core business, product development, and market access.

Judiciary

This committee oversees antitrust laws and intellectual property, both critical for the medical device industry's innovation, market competition, and protection of patented technologies crucial to Penumbra.

Veterans' Affairs

This committee directly oversees the Department of Veterans Affairs, whose funding decisions significantly impact government healthcare contractors and medical device manufacturers like Penumbra, as the VA is a major healthcare provider and purchaser.